Introduction and Overview of Myeloma
Case Discussion 1: When Should Systemic Myeloma Treatment Be Initiated?
- Accurate diagnosis of MM and assessment of risk
- Techniques and biomarkers for diagnosis
Case Discussion 2: Individualized Approaches to Frontline Treatment
- Understanding how patient and disease factors guide therapy decisions
- Optimal induction, consolidation, and maintenance approaches for individual patients
- Supportive care strategies for patients undergoing treatment for MM
Case Discussion 3: Therapeutic Strategies for Relapsed or Refractory Myeloma
- Planning optimal agent combinations for therapy
- New and future options for relapsed/refractory disease
Conclusions and Audience Question and Answer Session
Sarah Holstein, MD
Division of Oncology and Hematology
Department of Internal Medicine
University of Nebraska Medical Center
The goal of this activity is to improve participants’ competence to provide optimal care for patients with multiple myeloma.
This program is intended for physicians, registered nurses, pharmacists, and other healthcare providers who care for patients with multiple myeloma.
- Integrate timely systemic treatment for appropriate patients based on current multiple myeloma diagnosis and staging criteria
- Plan individualized treatment strategies for patients with multiple myeloma through consideration of the available clinical data as well as risk assessment, comorbidities, and patient age/fitness and preferences
- Describe the efficacy and safety evidence of novel combination therapeutic regimens for patients with multiple myeloma
- Identify ongoing trials of investigational approaches in the treatment of multiple myeloma to aid referral of patients for study participation
Physician Continuing Medical Education
The Annenberg Center for Health Sciences at Eisenhower is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The Annenberg Center for Health Sciences at Eisenhower designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing Continuing Education
Annenberg Center for Health Sciences is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
1.0 contact hour may be earned for successful completion of this activity.
Provider approved by the California Board of Registered Nursing, Provider Number 13664, for 1.0 contact hour. A statement of credit will be issued only upon receipt of a completed activity evaluation form and will be emailed to you within 3 weeks.
Pharmacist Continuing Education
The Annenberg Center for Health Sciences at Eisenhower is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
This program has been assigned ACPE Universal Activity #0797-9999-18-222-L01-P. This program is designated for up to 1.0 contact hour (0.10 CEUs) of continuing pharmacy education credit.
Type of Activity: Application
For Pharmacists: Upon receipt of the completed activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 4 weeks.
Disclosure of Conflicts of Interest
The Annenberg Center for Health Sciences at Eisenhower requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to the Annenberg Center for Health Sciences at Eisenhower policy. The existence or absence of COI for everyone in a position to control content will be disclosed to participants prior to the start of each activity.